Showing results (241-250 of 417) with videos related to

Sort By:
Pageof 42
Journal of Clinical Gastroenterology|September 7, 2012
Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoproteinStephen A Harrison, Djamal Abdurakhmanov, Mitchell L Shiffman, et al.
Hepatology (Baltimore, Md.)|December 25, 2004
Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantationScott J Weston, Rachel L Leistikow, K Rajender Reddy, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 29, 2015
HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscapeNancy Reau, Michael W Fried, David R Nelson, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 8, 2015
High risk of delisting or death in liver transplant candidates following infections: Results from the North American Consortium for the Study of End-Stage Liver DiseaseK Rajender Reddy, Jacqueline G O'Leary, Patrick S Kamath, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|September 17, 2025
Challenges in the Treatment of Hepatorenal Syndrome-Acute Kidney Injury: A US Chart Review of Treatment Patterns and Survival OutcomesArun J Sanyal, K Rajender Reddy, Kimberly A Brown, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 5, 2020
A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular CarcinomaNaga P Chalasani, Tiruvidaimarudur S Ramasubramanian, Abhik Bhattacharya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2008
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2aPatrick Marcellin, George K K Lau, Stefan Zeuzem, et al.
Annals of Internal Medicine|April 22, 2009
Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trialDonald M Jensen, Patrick Marcellin, Bradley Freilich, et al.
Pageof 42